Skip to main content
Erschienen in: European Radiology 1/2019

18.06.2018 | Oncology

Diagnosis of diffuse spleen involvement in haematological malignancies using a spleen-to-liver attenuation ratio on contrast-enhanced CT images

verfasst von: Christian Philipp Reinert, Clemens Hinterleitner, Jan Fritz, Konstantin Nikolaou, Marius Horger

Erschienen in: European Radiology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We aimed to test the hypothesis that the spleen-to-liver-attenuation ratio on portal-venous enhancement phase CT images can identify diffuse splenic infiltration in subjects with lymphoma.

Methods

A database search yielded 70 subjects with malignant haematological diseases who underwent contrast-enhanced CT (CECT) between December 2010 and March 2018. Additionally, consecutive control subjects were evaluated. We compared the splenic volume, splenic attenuation, spleen-to-liver, spleen-to-aorta and spleen-to-musculature ratios on portal-venous phase CECT images, pre- to post-treatment and between the different lymphoma entities. The standard of reference for splenic involvement was normalisation of the spleen volume following chemotherapy or normalisation of FDG-uptake.

Results

In subjects with diffuse splenic involvement, the spleen attenuation was significantly lower before treatment (93.48 HU) compared to controls (112.39 HU; p < .01) and after successful treatment (113.39 HU; p < .01). The spleen-to-liver attenuation ratio significantly increased after treatment (p < .001) and proved significantly lower at baseline when compared to control subjects (p < .01). The spleen volume significantly decreased after successful treatment (from 586.14.87 cm3 to 284.90 cm3; p < .001). Spleen-to-liver ratio significantly increased in lymphoma patients after therapy, inversely correlating with the decline in FDG-uptake (n=10) even in patients with normal-sized spleens (2/10), staying unchanged at follow-up. The outcome variables were not significantly different between the lymphoma subtypes.

Conclusions

We suggest the additional use of spleen-to-liver attenuation ratio to splenic volume alone for detection of diffuse splenic infiltration in subjects with lymphoma. The course of spleen-to-liver attenuation ratio inversely correlated with that of FDG-uptake in a subgroup of patients working accurately in normal-sized diffusely involved spleens.

Key Points

Involvement of the spleen is frequent in haematological malignancies and is important for staging and appropriate treatment.
Diffuse splenic infiltration often results in only homogeneous splenomegaly without a focal lesion, but even no or only minimal increase in splenic volume is possible. In these cases diagnosis of spleen involvement is a challenge for the radiologist.
Our data support the use of the spleen-to-liver attenuation ratio in addition to size measurements for the detection of diffuse splenic infiltration in subjects with lymphoma.
Literatur
1.
Zurück zum Zitat Olweny CL (1990) Cotswolds modification of the Ann Arbor staging system for Hodgkin's disease. J Clin Oncol 8:1598CrossRef Olweny CL (1990) Cotswolds modification of the Ann Arbor staging system for Hodgkin's disease. J Clin Oncol 8:1598CrossRef
2.
Zurück zum Zitat Bhatia K, Sahdev A, Reznek RH (2007) Lymphoma of the spleen. Semin Ultrasound CT MR 28:12–20CrossRef Bhatia K, Sahdev A, Reznek RH (2007) Lymphoma of the spleen. Semin Ultrasound CT MR 28:12–20CrossRef
3.
Zurück zum Zitat Saboo SS, Krajewski KM, O'Regan KN et al (2012) Spleen in haematological malignancies: spectrum of imaging findings. Br J Radiol 85:81–92CrossRef Saboo SS, Krajewski KM, O'Regan KN et al (2012) Spleen in haematological malignancies: spectrum of imaging findings. Br J Radiol 85:81–92CrossRef
4.
Zurück zum Zitat Leite NP, Kased N, Hanna RF et al (2007) Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies. Radiographics 27:1613–1634CrossRef Leite NP, Kased N, Hanna RF et al (2007) Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies. Radiographics 27:1613–1634CrossRef
5.
Zurück zum Zitat Cronin CG, Swords R, Truong MT et al (2010) Clinical utility of PET/CT in lymphoma. AJR Am J Roentgenol 194:W91–w103CrossRef Cronin CG, Swords R, Truong MT et al (2010) Clinical utility of PET/CT in lymphoma. AJR Am J Roentgenol 194:W91–w103CrossRef
6.
Zurück zum Zitat de Jong PA, van Ufford HM, Baarslag HJ et al (2009) CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. AJR Am J Roentgenol 192:745–753CrossRef de Jong PA, van Ufford HM, Baarslag HJ et al (2009) CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. AJR Am J Roentgenol 192:745–753CrossRef
7.
Zurück zum Zitat Hoffmann M, Kletter K, Becherer A, Jager U, Chott A, Raderer M (2003) 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology 64:336–340CrossRef Hoffmann M, Kletter K, Becherer A, Jager U, Chott A, Raderer M (2003) 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology 64:336–340CrossRef
8.
Zurück zum Zitat Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579–586CrossRef Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579–586CrossRef
9.
Zurück zum Zitat Juweid ME, Stroobants S, Hoekstra OS et al (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25:571–578CrossRef Juweid ME, Stroobants S, Hoekstra OS et al (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25:571–578CrossRef
10.
Zurück zum Zitat Nakachi S, Okada M, Morishima S et al (2017) Clinical usefulness of FDG-PET/CT for the evaluation of various types of adult T-cell leukemia. Hematology 22:536–543CrossRef Nakachi S, Okada M, Morishima S et al (2017) Clinical usefulness of FDG-PET/CT for the evaluation of various types of adult T-cell leukemia. Hematology 22:536–543CrossRef
11.
Zurück zum Zitat Kirchner J, Deuschl C, Grueneisen J et al (2017) (18)F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed? Eur J Nucl Med Mol Imaging 44:1005–1013CrossRef Kirchner J, Deuschl C, Grueneisen J et al (2017) (18)F-FDG PET/MRI in patients suffering from lymphoma: how much MRI information is really needed? Eur J Nucl Med Mol Imaging 44:1005–1013CrossRef
12.
Zurück zum Zitat Weissleder R, Elizondo G, Stark DD et al (1989) The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide. AJR Am J Roentgenol 152:175–180CrossRef Weissleder R, Elizondo G, Stark DD et al (1989) The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide. AJR Am J Roentgenol 152:175–180CrossRef
13.
Zurück zum Zitat van Krieken JH, Feller AC, te Velde J (1989) The distribution of non-Hodgkin's lymphoma in the lymphoid compartments of the human spleen. Am J Surg Pathol 13:757–765CrossRef van Krieken JH, Feller AC, te Velde J (1989) The distribution of non-Hodgkin's lymphoma in the lymphoid compartments of the human spleen. Am J Surg Pathol 13:757–765CrossRef
14.
Zurück zum Zitat Marx A, Muller-Hermelink HK, Hartmann M et al (2008) Lymphomas of the spleen. Pathologe 29:136–142CrossRef Marx A, Muller-Hermelink HK, Hartmann M et al (2008) Lymphomas of the spleen. Pathologe 29:136–142CrossRef
15.
Zurück zum Zitat Falk S (1991) Malignant lymphoma of the spleen. Histological and immunohistochemical studies of morphology and differential diagnosis. Veroff Pathol 136:1–265PubMed Falk S (1991) Malignant lymphoma of the spleen. Histological and immunohistochemical studies of morphology and differential diagnosis. Veroff Pathol 136:1–265PubMed
16.
Zurück zum Zitat Barrington SF, Kluge R (2017) FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging 44:97–110CrossRef Barrington SF, Kluge R (2017) FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging 44:97–110CrossRef
17.
Zurück zum Zitat Rini JN, Manalili EY, Hoffman MA et al (2002) F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Clin Nucl Med 27:572–577CrossRef Rini JN, Manalili EY, Hoffman MA et al (2002) F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Clin Nucl Med 27:572–577CrossRef
18.
Zurück zum Zitat Paes FM, Kalkanis DG, Sideras PA, Serafini AN (2010) FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics 30:269–291CrossRef Paes FM, Kalkanis DG, Sideras PA, Serafini AN (2010) FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics 30:269–291CrossRef
19.
Zurück zum Zitat Rueffer U, Sieber M, Josting A et al (1999) Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's disease: a retrospective analysis of the GHSG. Ann Oncol 10:1343–1348CrossRef Rueffer U, Sieber M, Josting A et al (1999) Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's disease: a retrospective analysis of the GHSG. Ann Oncol 10:1343–1348CrossRef
20.
Zurück zum Zitat Sandrasegaran K, Robinson PJ, Selby P (1994) Staging of lymphoma in adults. Clin Radiol 49:149–161CrossRef Sandrasegaran K, Robinson PJ, Selby P (1994) Staging of lymphoma in adults. Clin Radiol 49:149–161CrossRef
22.
Zurück zum Zitat Shirkhoda A, Ros PR, Farah J, Staab EV (1990) Lymphoma of the solid abdominal viscera. Radiol Clin N Am 28:785–799PubMed Shirkhoda A, Ros PR, Farah J, Staab EV (1990) Lymphoma of the solid abdominal viscera. Radiol Clin N Am 28:785–799PubMed
23.
Zurück zum Zitat Shi F, Zhou Q, Gao Y, Cui XQ, Chang H (2016) Primary splenic B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a case report. Oncol Lett 12:1925–1928CrossRef Shi F, Zhou Q, Gao Y, Cui XQ, Chang H (2016) Primary splenic B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a case report. Oncol Lett 12:1925–1928CrossRef
24.
Zurück zum Zitat Lee JE, Cho JS, Shin KS et al (2016) Diffuse infiltrative splenic lymphoma: diagnostic efficacy of arterial-phase CT. Korean J Radiol 17:734–741CrossRef Lee JE, Cho JS, Shin KS et al (2016) Diffuse infiltrative splenic lymphoma: diagnostic efficacy of arterial-phase CT. Korean J Radiol 17:734–741CrossRef
25.
Zurück zum Zitat Robertson F, Leander P, Ekberg O (2001) Radiology of the spleen. Eur Radiol 11:80–95CrossRef Robertson F, Leander P, Ekberg O (2001) Radiology of the spleen. Eur Radiol 11:80–95CrossRef
26.
Zurück zum Zitat Rini JN, Leonidas JC, Tomas MB, Palestro CJ (2003) 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 44:1072–1074PubMed Rini JN, Leonidas JC, Tomas MB, Palestro CJ (2003) 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 44:1072–1074PubMed
27.
Zurück zum Zitat Munker R, Stengel A, Stabler A, Hiller E, Brehm G (1995) Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Verification by laparotomy in 100 cases. Cancer 76:1460–1466CrossRef Munker R, Stengel A, Stabler A, Hiller E, Brehm G (1995) Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Verification by laparotomy in 100 cases. Cancer 76:1460–1466CrossRef
Metadaten
Titel
Diagnosis of diffuse spleen involvement in haematological malignancies using a spleen-to-liver attenuation ratio on contrast-enhanced CT images
verfasst von
Christian Philipp Reinert
Clemens Hinterleitner
Jan Fritz
Konstantin Nikolaou
Marius Horger
Publikationsdatum
18.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 1/2019
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5556-2

Weitere Artikel der Ausgabe 1/2019

European Radiology 1/2019 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.